Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Laryngoscope. 2010 Jun;120(6):1159–1165. doi: 10.1002/lary.20917

Table III. Biomarker Expression of the Entire Tissue Sample by Western or in the Basal Cell Layer by IHC.

Western*
Tumors p-AKT p-MTOR p-S6 p-4EBP1
 + 32 18 17 10
 - 12 12 27 34
 Total 44 30 44 44
Junctional Zone
 + 16 13 11 10
 - 1 3 8 9
 Total 17 16 19 19
 Sensitivity Tumors 72.7% 60.0% 38.6% 22.7%
 Junctional Zone 94.1% 81.3% 57.9% 52.6%

IHC
Tumors p-MTOR p-4EBP1
 + 59 36
 - 13 36
 Total 72 72
Uvula
 + 0 1
 - 22 21
 Total 22 22
 Sensitivity 81.9% 50.0%
 Specificity 100% 95.5%